Post by
TheLandedEagles on May 10, 2024 11:03am
Only Good News here..They gave new Goal Date for Approval..
PharmaTher received that final Complete Response Letter, and PharmaTher responded with their comments and further testing with their thoughts of deficientcies and positive results. This is only GOOD news, only extends the period for FDA approval to October 2024..Delay is only what we have here..other potential news to come..Pharma partnerships, for Ketrax and its distribution and commercialization which also to include their PharmaPatch product. Ongoing and anticipated this quarter Clinical results and their Sairiyo spin-out announcement....ALL GOOD, in my opinion..JUST MORE DELAYS..Ketrax is in demand around the world, clients are waiting and wanting this product thats in very short supplier. Its on FDA's list of short supply since 2018 and for Canada has well since 2022. This has buyers lining up...will bring in large revenues very quickly. There should be no concern whether PharmaTher has clients that is willing to buy Ketrax..ITS A DEMANDED PRODUCT and used by the medical community around the world with little to no competition..No brainer here, just time to get to that final FDA approval...its a 99.9999% garantee in my opinion. Good Luck, I'm still holding and buying on this dips...To each their own..Don't get spooked by market reactions..only good news here..